中国科技论文统计源期刊 中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库(JST)
第七届湖北十大名刊提名奖  
医药导报, 2016, 35(12): 1364-1368
doi: 10.3870/j.issn.1004-0781.2016.12.017
微生态制剂联合早期肠内营养对重型颅脑损伤患者临床结局指标影响的Meta分析
Meta-analysis of the Effect of Probiotics Combined with Early Enteral Nutrition on Clinical Outcome of Severe Traumatic Brain Injury Patients
雷婷1,, 汪泳2, 于刚2, 刘丽萍1,, 王媛媛1

摘要:

目的 系统评价微生态制剂联合早期肠内营养对重型颅脑损伤患者临床结局指标的影响。方法 利用计算机检索建库至2015年4月国内外文献数据库,包括PubMed、Cochrane Library、 Embase、中国生物医学文献数据库(CBM) 、中国期刊全文数据库(CNKI)及维普数据库(VIP)等,纳入微生态制剂联合早期肠内营养对重型颅脑损伤患者临床结局指标影响的随机对照试验( RCTs ) 文献。对纳入的研究进行方法学质量评价,并采用RevMan5.2.0软件进行Meta分析。结果 共7篇随机对照试验文献的研究符合纳入标准。Meta分析结果显示:微生态制剂联合早期肠内营养可以缩短重症颅脑损伤患者的ICU住院日[MD=-4.73,95%CI=(-6.45,-3.00),P<0.000 01],降低病死率[RR=0.44,95%CI=(0.30,0.66),P<0.000 1],降低总感染率[RR=0.52,95%CI=(0.39,0.68),P<0.000 1]。结论 微生态制剂联合早期肠内营养可以改善重症颅脑损伤患者的临床结局。

关键词: 微生态制剂 ; 肠内营养 ; 损伤 ; 颅脑

Abstract:

Objective To explore the effect of probiotics combined with early enteral nutrition on clinical outcome of severe traumatic brain injury patients. Methods PubMed, Embase, the Cochrane Library, CBM, CNKI and VIP were searched to indentify randomized controlled trails (RCTs) concerning probiotics combined with early enteral nutrition in treatment of severe traumatic brain injury patients.Methodological quality of included studies was evaluated, and data were analyzed with The Cochrane Collaboration's soft ware RevMan 5.2.0. Results Seven prospective RCTs met the criteria.Meta analysis showed that probiotics combined with early enteral nutrition could shorten the length of ICU stay [MD=-4.73, 95%CI=(-6.45,-3.00), P<0.000 01], reduce mortality rates [RR=0.44, 95%CI=0.30,0.66, P<0.0001], reduce overall infection rates [RR=0.52, 95%CI=(0.39,0.68), P<0.000 1]. Conclusion Probiotics combined with early enteral nutrition could improve the clinical outcomes of severe brain injury patients.

Key words: Probiotics ; Enteral nutrition ; Injury ; traumatic brain

颅脑损伤是指外界暴力直接或间接作用于头部造成的损伤。伤后昏迷时间>6 h或者再次发生昏迷者称为重型颅脑损伤[1]。颅脑严重受损后,机体易出现严重的应激反应,应激期间代谢水平明显增高,免疫功能受到抑制,易导致患者并发继发感染,严重时出现全身脏器功能衰竭,危及生命。 因而寻求新的治疗方法以改善患者的临床结局是目前的研究热点之一。 微生态制剂(microecologics)又称为微生态调节剂(microecological),是根据微生态学基本原理,利用人体正常菌群成员或对其有促进作用的其他微生物等物质制成的生物制品。随着研究的不断深入,越来越多的微生态制剂联合早期肠内营养运用于重型颅脑损伤患者的治疗中,众多研究报道指出,在早期肠内营养支持的基础上添加微生态制剂,有利于纠正肠道微生态失衡,维持肠黏膜通透性,减少细菌易位。本研究旨在采用Meta分析探讨微生态制剂联合早期肠内营养对重型颅脑损伤患者结局指标的影响,从而使其在临床得到合理应用,现报道如下。

1 资料与方法
1.1 资料来源

利用计算机检索建库至2015年4月国内外文献数据库,包括PubMed、Cochrane Library、 Embase、中国生物医学文献数据库(CBM)、中国期刊全文数据库(CNKI)及维普数据库(VIP)等。英文检索词包括(“brain injury”or“cerebral injury”or“brain trauma”or“cerebral trauma”or“head trauma”or“head injury”)和(“probiotics” or“ bifidobacterium” or “bacillus subtilis”等)和(“nutrition”);中文检索词包括(“重型颅脑损伤”、“颅脑损伤”等)和(“益生菌”“合生元”“益生元”“微生态制剂”等)和(“肠内营养”“营养支持”等)。所有检索采用主题词与自由词相结合的方式检索。

1.2 文献纳入与排除标准

纳入标准:①研究设计:均为随机对照的临床研究(randomized controlled trials,RCT),并设立平行对照,排除自身对照和交叉试验;②试验对象:临床和CT均证实为重型颅脑损伤患者;③干预措施:分为试验组和对照组,试验组给予微生态制剂联合早期肠内营养,对照组给予早期肠内营养;两组实施肠内营养时营养液输注的滴速、温度、 渗透压以及其他治疗均相同 ;④结局指标:ICU住院时间,病死率,总感染率。

1.3 文献质量评价标准

由2名研究参与人员对检索文章进行质量评价和资料提取,若意见分歧由两人讨论后进行解决,本研究采用cochrane handbook for systematic reviews of intervention推荐的偏倚风险评估工具对纳入的RCT进行质量评价:①随机方法是否正确;②是否做到分配隐藏;③是否采用盲法;④不完整资料报告;⑤选择性结果报告;⑥其他偏倚。

1.4 统计学方法

采用RevMan 5.2.0版软件进行Meta分析。首先对纳入的研究进行异质性分析,然后根据异质来源对各研究进行亚组分析,异质性分析采用χ2检验,若P ≥ 0.05 且I2 ≤ 50 %时应用固定效应模型分析;当P<0.05且I2>50%时应用随机效应模型分析。Meta分析的检验水准为α=0.05,其结果采用森林图呈现。

2 结果
2.1 纳入文献特征与质量

通过检索电子数据库,共检索到微生态制剂联合早期肠内营养对重度颅脑损伤患者结局指标影响的文献共121篇,通过阅读题名、摘要,排除综述、动物实验、个案报道等,剩余随机对照研究共18篇,按照纳入标准进行筛选,最终有7篇RCT进行研究分析,共纳入患者476例,其中试验组234例,对照组242例。7篇文献中1篇为英文文献,6篇为中文文献。纳入研究的文献具体情况。见表1。

表1 纳入研究的基本特征
Tab.1 Baseline characteristics of the included studies
纳入研究 例数 平均年龄/岁 性别
试验组 对照组 试验组 对照组 试验组 对照组
TAN等[2] 26 26 40.5±13 40.8±12.8 19 7 21 5
熊小伟等[3] 17 21 48.8±8.5 40.1±8.8 15 2 16 5
葛红娟等[4] 35 35 49.2±6.3 48.9±5.9 未详细说明
陈露萍等[5] 53 57 40.5±3.8 40.3±4.0 31 22 33 24
韩东景等[6] 41 41 71.8±5.0 70.5±5.2 24 17 25 16
彭华军等[7] 31 31 53.1±2.6 51.9±2.4 19 12 20 11
秦德广[8] 31 31 未详细说明 未详细说明
纳入研究 试验组 对照组 疗程 观察指标
TAN等[2] 肠内营养乳剂+双歧杆菌乳杆 肠内营养乳剂 21 d 病死率,总感染率,ICU住院时间
菌三联活菌片
熊小伟等[3] 肠内营养混悬液(+双歧 肠内营养混悬液 15 d 病死率,ICU住院时间
杆菌乳杆菌三联活菌片间
葛红娟等[4] 肠内营养混悬液+ 双歧杆菌 肠内营养混悬液 15 d 病死率,总感染率
乳杆菌三联活菌片
陈露萍等[5] 肠内营养混悬液+ 酪酸梭菌 肠内营养混悬液 21 d 病死率,总感染率,ICU住院时间
活菌片
韩东景等[6] 肠内营养乳剂+双歧杆菌乳杆 肠内营养乳剂 14 d 病死率,总感染率,ICU住院时间
菌三联活菌片
彭华军等[7] 肠内营养混悬液+双歧 肠内营养混悬液 21 d ICU住院时间
杆菌乳杆菌三联活菌
秦德广等[8] 肠内营养混悬液+双歧杆菌 肠内营养混悬液 未详细描述 ICU住院时间,病死率
四联活菌

表1 纳入研究的基本特征

Tab.1 Baseline characteristics of the included studies

2.2 纳入研究的质量评价

本研究纳入的7篇文献均为RCT文献,3个研究正确描述了文献随机序列产生的方法,1个研究说明了分配隐藏和盲法的使用,7个研究均完成了干预治疗,并进行了随访统计。见图1。

图1 Cochrane偏倚风险图

Fig.1 Figure of the risk of Cochrane bias

2.3 微生态制剂联合早期肠内营养对重型颅脑损伤患者结局指标的影响

2.3.1 对患者ICU住院时间的影响 本组共有5个研究(344例)报告患者行微生态制剂联合早期肠内营养支持后的ICU住院时间,经分析提示χ2=21.53,P=0.000 2,I2=81%,各研究间具有异质性,采用随机效应模型并发并进行分析。结果显示微生态制剂联合早期肠内营养支持对于重症颅脑损伤患者ICU住院时间有所降低,差异有统计学意义,并发后的MD值为-4.73,95%CI为(-6.45,-3.00),P<0.000 01,见图2。

2.3.2 对患者病死率的影响 本组共有6个研究(414例)报告了微生态制剂联合早期肠内营养支持对重症颅脑损伤患者病死率的影响,经分析提示χ2=1.12,P=0.95,I2=0%,各研究间不存在异质性,采用固定效应模型并发并进行分析。结果显示微生态制剂联合早期肠内营养支持对于重症颅脑损伤患者病死率有所降低,差异有统计学意义,并发后RR值为0.44,95%CI为(0.30,0.66),P<0.000 1。见图3。

2.3.3 对患者总感染率的影响 本组共有5个研究(376例)报告了微生态制剂联合早期肠内营养支持对重症颅脑损伤患者总感染率的影响,经分析提示χ2=2.33,P=0.68,I2=0%,各研究间不存在异质性,采用固定效应模型并发并进行分析。结果显示微生态制剂联合早期肠内营养支持对于重症颅脑损伤患者总感染率有所降低,差异有统计学意义,并发后RR值为0.52,95%CI为(0.39,0.68),P<0.000 1,见图4。

图2 微生态制剂联合早期肠内营养对患者ICU住院时间的影响

Fig.2 Effect of probiotics combined with early enteral nutrition on hospitalization period of the patients in ICU

图3 微生态制剂联合早期肠内营养对患者病死率的影响

Fig.3 Effect of probiotics combined with early enteral nutrition on mortality rate of the patients in ICU

图4 微生态制剂联合早期肠内营养对患者总感染率的影响

Fig.4 Effect of probiotics combined with early enteral nutrition on overall infection rate of the patients in ICU

3 讨论

重度颅脑损伤是临床常见的神经外科危重疾病,患者受伤后由于应激等因素导致免疫功能下降,肠屏障功能受损,机体出现严重菌群失调,如果这个过程得不到遏制,将严重影响患者的预后[9-10]。因此,促进重型颅脑损伤患者受伤后肠道功能的修复,维持肠道菌群的平衡,促进机体免疫功能恢复显得尤为重要。近年来,微生态制剂联合早期肠内营养对危重患者康复的意义逐步被人们所认识,相关的研究与应用也随之被人们所重视,微生态制剂可以改变肠道菌群比例及转化某些肠内物质。拮抗结合位点,阻止致病菌定植。调节抗炎与促炎因子之间的平衡,促进损伤上皮修复以及增强上皮紧密连接,加强肠黏膜屏障保护作用,阻止细菌移位等[11-12]。有临床研究已表明,微生态制剂联合早期肠内营养可以明显降低危重患者感染率,缩短入住ICU 的时间及使用呼吸机的天数[13-14]

目前,微生态制剂联合早期肠内营养在重症颅脑损伤患者中的应用已有较多的报道,但由于亦有研究得出了不一致的结果,导致在临床实践过程中对于微生态制剂联合肠内营养是否值得应用的问题,尚存在不同观点。而Meta分析是循证医学的重要研究方法,用来比较和综合针对同一类科学问题所取得的研究结果,使多个独立研究的个体得到全面、系统和定量的观察的观察和评价。本研究采用Meta分析系统评价了微生态制剂联合早期肠内营养对重症颅脑损伤患者临床结局指标的影响。通过评价发现,微生态制剂联合早期肠内营养支持可明显缩短重症颅脑损伤患者的ICU住院时间[MD=-4.73,95%CI=(-6.45,-3.00),P<0.000 01],降低病死率[RR=0.44,95%CI=(0.30,0.66),P<0.000 1],降低总感染率[RR=0.52,95%CI=(0.39,0.68),P<0.000 1]。本次分析的局限性在于纳入的研究样本量仍较少,部分研究的质量较低,关于微生态制剂联合早期肠内营养应用于重症颅脑损伤的确切效用,尚需要开展更多大样本的随机对照试验做进一步的评估。同时研究者能够更加详尽报道研究的设计和实施过程,提高研究质量,为二次评价提供高质量的证据支持。

The authors have declared that no competing interests exist.

参考文献

[1] DUDRICK S J,PANAIT I.Metabolic consequences of patients with gastrointestinal fistulas[J].Eur J Trauma Emerg S,2011,37(3):215-225.
ABSTRACT Methods and MaterialsThe historical highlights of the management of fistulas of the gastrointestinal tract during the past century are presented briefly, together with the significant lessons learned from the studies published in the literature. DiscussionThe evolution from predominantly operative or technical approaches to comprehensive multidisciplinary management of metabolic and nutritional support, which are essential to optimal fistula closure, and morbidity and mortality outcomes are discussed. The importance of achieving hemodynamic stability, fluid and electrolyte homeostasis, fistula effluent control, protection of the skin, control of infection and sepsis, and cardiopulmonary and major organ support, preferably by specially trained and motivated teams in critical care units of institutions with the interest, resources, and skills in managing the metabolic consequences of gastrointestinal fistula patients, is emphasized. The current status of the nutritional and metabolic support of patients with gastrointestinal tract fistulas is outlined and discussed briefly. ConclusionsThe optimal metabolic and nutritional management of patients with gastrointestinal tract fistulas is an extraordinary and daunting challenge which has yet to be perfected, demonstrated, and applied universally. Much education, research, motivation, proficiency, and concerted conscientious effort will be required in order to achieve this elusive but noble goal. Some suggestions for achieving success in this endeavor are proffered, consistent with the senior author&rsquo;s philosophy, which has evolved during a half-century of experience and endeavor in this vital area. KeywordsEnterocutaneous fistula&ndash;Gastrointestinal fistula&ndash;Enteral nutrition&ndash;Parenteral nutrition&ndash;Nutritional support&ndash;Metabolism
DOI:10.1007/s00068-011-0102-9      PMID:26815103      Magsci     URL    
[本文引用:1]
[2] TAN M,ZHU J C,DU J,et al.Effect of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients:a prospective randomized pilot study[J].Crit Care,2011,15(6):R290.
Traumatic brain injury (TBI) is associated with a profound immunological dysfunction manifested by a severe shift from T-helper type 1 (Th1) to T-helper type 2 (Th2) response. This predisposes patients to infections, sepsis, and adverse outcomes. Probiotic bacteria have been shown to balance the Th1/Th2 cytokines in allergic murine models and patients. For the present study, we hypothesized that the enteral administration of probiotics would adjust the Th1/Th2 imbalance and improve clinical outcomes in TBI patients.We designed a prospective, randomized, single-blind study. Patients with severe TBI and Glasgow Coma Scale scores between 5 and 8 were included, resulting in 26 patients in the control group and 26 patients in the probiotic group. All patients received enteral nutrition via a nasogastric tube within 24 to 48 hours following admission. In addition, the probiotic group received 109 bacteria of viable probiotics per day for 21 days. The associated serum levels of Th1/Th2 cytokines, Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores, nosocomial infections, length of ICU stay, and 28-day mortality rate were studied.The patients responded to viable probiotics, and showed a significantly higher increase in serum IL-12p70 and IFN纬 levels while also experiencing a dramatic decrease in IL-4 and IL-10 concentrations. APACHE II and SOFA scores were not significantly affected by probiotic treatment. Patients in the probiotic group experienced a decreased incidence of nosocomial infections towards the end of the study. Shorter ICU stays were also observed among patients treated with probiotic therapy. However, the 28-day mortality rate was unaffected.The present study showed that daily prophylactic administration of probiotics could attenuate the deviated Th1/Th2 response induced by severe TBI, and could result in a decreased nosocomial infection rate, especially in the late period.ChiCTR-TRC-10000835.
DOI:10.1186/cc10579      PMID:3388628      URL    
[本文引用:0]
[3] 熊小伟,周已焰,董荔,.益生菌联合早期肠内营养对重型颅脑损伤患者感染的影响[J].第三军医大学学报,2013,25(6):536-539.
目的观察益生菌联合早期肠内营养对重型颅脑损伤患者感染的影响。方法选取重型颅脑损伤患者38例,按随机数字表分为研究组(17例)和对照组(21例)。2组患者均在入院后24—72h内开始经鼻胃管行肠内营养,研究组在肠内营养基础上添加益生菌。于肠内营养开始后1、4、7、15d晨空腹抽血监测白细胞、淋巴细胞、C-反应蛋白等指标,记录患者感染发生时间、严重程度,观察患者预后情况,比较ICU住院天数和GCS、SOFA、APACHEⅡ评分。结果研究组白细胞计数在营养后7d显著低于对照组(P〈0.05),C-反应蛋白在15d显著低于对照组(P〈0.05),而淋巴细胞计数在各时相点两组差异均无统计学意义(P〉0.05)。研究组总感染发生率、肺部感染发生率也显著低于对照组(P〈0.05),其ICU住院天数明显降低(P〈0.05)。在营养第15天,研究组GCS评分显著高于对照组(P〈0.05)。结论与单纯早期肠内营养相比,添加益生菌能更好地降低重型颅脑损伤患者的感染发生率,缩短ICU住院天数,改善患者的预后。
URL    
[本文引用:0]
[4] 葛红娟,王奇,郭英,.益生菌联合早期肠内营养治疗对重型颅脑损伤患者感染的临床研究[J].中华医院感染学杂志,2014,24(17):4324-4327.
目的探讨益生菌联合早期肠内营养对重型颅脑损伤患者感染的影响,以期提高临床治疗水平。方法随机选取2010年1月-2013年2月70例重型颅脑损伤感染患者为研究对象,将其随机分为对照组和观察组,各35例,对照组予以早期肠内营养,观察组在对照组基础上加用益生菌治疗,观察两组治疗效果。结果对照组与观察组在治疗后的第1天白细胞计数、淋巴细胞计数、C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)比较,差异无统计学意义;而在治疗后的第4、7、15天两组比较,各项指标差异均有统计学意义(P<0.05);对照组感染率为48.57%、病死率为14.29%,观察组分别为25.71%和5.71%;两组治疗后在GCS评分、SOFA评分、APACHF-Ⅱ评分上比较,差异有统计学意义(P<0.05)。结论益生菌联合早期肠内营养对重型颅脑损伤患者感染影响性低,临床效果满意。
DOI:10.11816/cn.ni.2014-133925      URL    
[本文引用:0]
[5] 陈露萍,刘维群,程军.早期肠内营养联合益生菌对重型里脑损伤患者术后感染的影响研究[J].中华医院感染学杂志,2015,25(6):1357-1360.
目的:探讨早期肠内营养联合益生菌对重型颅脑损伤患者术后感染的 影响,以降低感染率。方法选取重型颅脑损伤手术患者110例,随机分为两组,对照组53例给予早期肠内营养治疗,观察组57例在对照组基础上给予益生菌联 合应用,对两组患者住院期间发生感染进行统计,采用 SPSS13.0软件进行分析。结果患者发生肺部感染率及总感染率观察组分别为19.30%及31.58%、对照组分别为30.19%及47.17%,观 察组均明显低于对照组;治疗7 d 时观察组患者白细胞计数为(9.88 ± 1.05)×109/L ,7、15 d 时 C-反应蛋白分别为(80.47 ± 7.92)、(19.79±2.20)mg/L ,对照组分别为(12.20 ± 1.19)×109/L 及(175.58±20.05)、(77.39 ± 9.30)mg/L ;治疗15 d 时患者 GCS 评分观察组为(12.43 ± 1.97)分、对照组为(9.18 ± 0.63)分;住院时间观察组为(6.40 ± 0.95)d 、对照组为(12.17 ± 1.82)d ;患者病死率观察组为14.04%、对照组为35.85%,两组差异均有统计学意义(P< 0.05)。结论对重型颅脑损伤患者在早期肠内营养的基础上给予益生菌联合应用有利于降低感染发生率,改善患者预后。
DOI:10.11816/cn.ni.2015-140581      URL    
[本文引用:0]
[6] 韩东景,陈文芳.合生元制剂联合早期肠内营养治疗老年重型颅脑损伤后感染的疗效[J].中国老年学杂志,2015,35(7):1819-1821.
目的探讨合生元制剂联合早期肠内营养对高龄重型颅脑损伤患者感染的影响。方法在该院接受治疗的82例高龄重型颅脑损伤患者,随机分成两组各41例。对照组接受重型颅脑损伤的常规抢救治疗,同时早期展开肠内营养支持治疗。观察组在对照组治疗方式的基础上,应用合生元制剂治疗。结果治疗3、7、10 d后,观察组患者的白细胞水平低于对照组(P0.01)。治疗3、7、10 d后,观察组患者的分泌型Ig A(SIg A)水平高于对照组(P0.01)。治疗后,观察组患者(格拉斯哥昏迷评分)GCS评分及光纤放大系统(SOFA)评分高于对照组(P0.01)。治疗后,观察组患者急性生理及慢性健康状况(APACHEⅡ)评分及重症监护病房(ICU)住院天数小于对照组(P0.01)。观察组患者的死亡率少于对照组(P0.05)。观察组患者总感染率少于对照组(P0.01)。结论合生元制剂联合早期肠内营养治疗老年重型颅脑损伤疗效显著,具有维持肠道菌群平衡、提高肠道黏膜免疫的作用,能够改善患者病情、降低患者感染风险和死亡率,促进患者的康复预后。
[本文引用:0]
[7] 彭华军,唐丹丹.不同早期肠内营养方案对严重颅脑外伤患者胃肠功能和营养状况的影响[J].中国实用神经疾病杂志,2015,18(1):3-5.
目的探讨不同早期肠内营养方案对严重颅脑外伤患者胃肠功能和营养状况的影响。方法收集我院2010-06—2013-06收治的严重颅脑外伤患者62例为研究对象,随机分为试验组与对照组,每组各31例。2组患者入院24h内开始肠内营养,试验组还同时给予益生菌。然后观察2组患者的呕吐、腹胀、胃潴留、反流、便秘及腹泻等胃肠道反应情况;观察患者的首次排便时间和肠内营养达标时间。于营养开始第0、6、14、21天检测患者的血清白蛋白、血红蛋白、空腹血糖及淋巴细胞计数等营养指标,并比较2组患者住ICU时间。结果 2组呕吐、腹胀、胃潴留、腹泻和住ICU时间比较差异均无统计学意义(P〉0.05)。试验组反流及便秘发生例数和营养支持第6、14天空腹血糖明显低于对照组。试验组营养支持第21天白蛋白及血红蛋白水平显著高于对照组。试验组的首次排便时间及肠内营养达标时间早于对照组。结论在肠内营养同时添加益生菌既可以改善严重颅脑损伤患者的胃肠功能,又可以提高患者机体的营养状况。
[本文引用:0]
[8] 秦德广. 生态营养在重型颅脑创伤中的应用[J].实用医学杂志,2011,27(11):1976-1977.
目的:观察重型颅脑创伤患者采用生态营养鼻饲肠内营养支持的效果。方法:选择我院62例重型颅脑创伤(GCS评分4~8分)患者作前瞻性研究。生态营养组于早期(伤后12h)开始双歧杆菌四联活菌片3#+30mL温水胃管注入。每日3次,同时给肠内营养混悬液持续胃管滴注;普通膳食组仅给肠内营养混悬液持续胃管滴注。结果:生态营养组支持后血清白蛋白、血清前白蛋白等营养指标明显优于普通膳食组(P〈0.05);胃肠道功能障碍症状(上消化道出血、胃内容物返流、症状性腹胀、腹泻和拒食等)明显少于普通膳食组(P〈0.05或P〈0.01),神志恢复快,生存质量有明显改善。结论:重型颅脑创伤患者早期给予生态营养可有效降低胃肠功能障碍的发生率,从而促进神经功能恢复,有效降低病死率和致残率。
[本文引用:0]
[9] SHIMIZU K,OGURA H,HAMASAKI T,et al.Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome[J].Dig Dis Sci,2011,56(4):1171-1177.
Gut under severe insult is considered to have an important role in promoting infection and multiple organ dysfunction syndrome from the viewpoint of altered intestinal epithelium, immune system and commensal bacteria. There are few reports, however, about the relationship between gut flora and septic complications.We analyzed gut flora in patients with systemic inflammatory response syndrome (SIRS) and evaluated key bacteria and their cutoff values for infectious complications and mortality by using classification and regression trees (CART). Eighty-one SIRS patients with a serum C-reactive protein level higher than 10mg/dL treated in the intensive care unit (ICU) for more than 2days were included for the study. We quantitatively evaluated nine types of bacteria in fecal samples by plate or tube technique. Two hundred seventy-one samples were analyzed using CART and logistic regression.The dominant factors for complication of enteritis were the minimum number of total obligate anaerobes and the maximum number of Staphylococcus and Enterococcus. The dominant factors for complication of bacteremia were the minimum numbers of total obligate anaerobes and total facultative anaerobes. The dominant factors for mortality were the numbers of total obligate anaerobes and total facultative anaerobes and age.A decrease in total obligate anaerobes and an increase in pathogenic bacteria in the gut are associated with septic complications and mortality in patients with SIRS. The altered gut flora may be a potential prognostic marker in SIRS patients.
DOI:10.1007/s10620-010-1418-8      PMID:20931284      URL    
[本文引用:1]
[10] AKYOL S,MAS M R,COMERT B,et al.The effect of antibiotic and probiotic combination therapy on secondary pancreatic infections and oxidative stress parameters in experimental acute necrotizing pancreatitis[J].Pancreas,2003,26(4):363-367.
Abstract INTRODUCTION: Ciprofloxacin and meropenem have effects on intestinal bacteria that are responsible for pancreatic infection, and on the basis of recent data it has been argued that probiotics, especially those used in the food industry, could improve efforts to prevent and treat secondary pancreatic infections by inhibiting bacterial translocation. AIMS: To evaluate the effects of probiotic treatment alone or in combination with early administration of two different antibiotics on serum amylase, pancreatic histopathology, bacterial translocation, and oxidative markers. METHODOLOGY: Acute pancreatitis was induced in rats with 3% sodium taurocholate (1 mL/kg intraductally), except in group VI (sham group). After the stabilization period, the rats were divided into seven groups (n = 20) randomly. At hour 6 after injection, group I rats received probiotic Saccharomyces boulardii (25 mg/d orally q.d.), group II received meropenem (60 mg/kg intraperitoneally b.i.d.), group III received ciprofloxacin (40 mg/kg intraperitoneally b.i.d.), group IV received the same dose of probiotic plus meropenem, and group V received probiotic plus ciprofloxacin. Treatment was not given to group VI (sham group) and group VII (pancreatitis group). At hour 48 after induction, specimens were collected. RESULTS AND CONCLUSION: Although histopathologic scores in treatment groups were found to be lower than in group VII, the difference was statistically significant only in group V (p < 0.001). In evaluation of oxidative stress, we found that MDA levels decreased and SOD levels increased in treatment groups in comparison with levels in group VII. Probiotic treatment alone reduced bacterial translocation. Probiotic-antibiotic combination therapy was shown to improve histopathologic scores and oxidative parameters.
DOI:10.1097/00006676-200305000-00009      PMID:12717269      URL    
[本文引用:1]
[11] FONTANA L,BERMUDEZ-BRITO M,PLAZA-DIAZ J,et al.Sources,isolation,characterisation and evaluation of probiotics[J].Br J Nutr,2013,109(Suppl 2):35-50.
[本文引用:1]
[12] CALDER P,HALL V.Understanding gut-immune interactions in management of acute infectious diarrhoea[J].Nurs Older People,2012,24(9):29-37,quiz 38-39.
This article discusses the role that immunity plays in the risk of diarrhoea and the potential role for probiotics in the management of acute infectious diarrhoea in older people, including antibiotic-associated diarrhoea and Clostridium difficile-associated diarrhoea.
DOI:10.7748/nop2012.11.24.9.29.c9367      PMID:23311278      URL    
[本文引用:1]
[13] BICKERT T,TRUJILLO-VARGAS C M,DUECHS M,et al.Probiotic Escherichiacoli Nissle 1917 suppresses allergen-induced Th2 responses in the airways[J].Int Arch Allergy Immunol,2009,149(3):219-230.
Recent clinical trials, epidemiological studies and animal experiments have suggested that probiotics may help suppress the development of allergic responses.To investigate whether the application of the probiotic Escherichia coli strain Nissle 1917 (EcN) protects mice from developing ovalbumin (OVA)-specific T helper-2 responses in the airways.OVA-specific Th2 responses were induced by 2 intraperitoneal (i.p.) injections with OVA/alum followed by 1 intranasal (i.n.) challenge with OVA. EcN was given orally during the entire sensitization and challenge period, together with OVA/alum during the i.p. sensitizations, or i.n. before or during the airway challenge with OVA.We found that when the bacteria were given together with OVA/alum airway eosinophilia, airway hyper-reactivity, goblet cell metaplasia and IL-5 levels in the bronchoalveolar lavage and mediastinal lymph node cell cultures were reduced. This effect was associated with increased numbers of IFN-gamma producing T helper-1 cells and IFN-gamma levels in the airways and strongly increased OVA-specific IgG(2a) titers in the serum. The suppressive effect on airway eosinophilia was dependent on IFN-gamma but not TLR-4. Applying EcN i.n. or orally did not reduce the development of allergen-specific Th2 responses.Our results suggest that EcN can inhibit the development of allergic responses when the bacteria are present at the site of Th2 cell priming and that this immunomodulatory effect is due to a shift from Th2 to Th1 response. The data support the hypothesis that probiotics may help reduce allergic responses and that EcN may also be used as adjuvant therapy to induce allergen-specific Th1 responses.
DOI:10.1159/000199717      PMID:25204696      URL    
[本文引用:1]
[14] KOTZAMPASSI K,GIAMARELLOS-BOURBOULIS E J,VOUDOURIS A,et al.Benefits of a synbiotic formula(Synbiotic 2000Forte)in critically ill trauma patients:early results of a randomized controlled trial[J].World J Surg,2006,30(10):1848-1855.
<a name="Abs1"></a><div class="AbstractSection"> <div class=""><h3>Background&nbsp;&nbsp;</h3>Since probiotics are considered to exert beneficial health effects by enhancing the host&#8217;s immune response, we investigated the benefits of a synbiotics treatment on the rate of infections, systemic inflammatory response syndrome (SIRS), severe sepsis, and mortality in critically ill, mechanically ventilated, multiple trauma patients. Length of stay in the intensive care unit (ICU) and number of days under mechanical ventilation were also evaluated.
DOI:10.1007/s00268-005-0653-1      Magsci    
[本文引用:1]
资源
PDF下载数    
RichHTML 浏览数    
摘要点击数    

分享
导出

相关文章:
关键词(key words)
微生态制剂
肠内营养
损伤
颅脑

Probiotics
Enteral nutrition
Injury
traumatic brain

作者
雷婷
汪泳
于刚
刘丽萍
王媛媛

LEI Ting
WANG Yong
YU Gang
LIU Liping
WANG Yuanyuan